Sinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be In Jeopardy

Sinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be In Jeopardy


Recently disclosed court documents show that Sinovac Biotech's CEO bribed a member of the Chinese Food and Drug Administration to assist its vaccine clinical trial and approval. Bribery is a clear violation of Foreign Corrupt Practices Act regulations and is prohibited for SEC registered companies like SVA; it could lead to criminal prosecution and fines.



from Biotech News